Cargando…

DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway

Multiple myeloma (MM) is an incurable plasma cell malignancy, in which alternative pre-mRNA splicing (AS) acts as one of the key transcriptome modifier. The Deleted in Azoospermia-Associated Protein 1 (DAZAP1) is a splicing factor that has been identified as an oncogene in multiple cancers, yet its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yanyan, Huangfu, Shaohua, Li, Muxi, Tang, Chao, Qian, Jinjun, Guo, Mengjie, Zhou, Zuojian, Yang, Ye, Gu, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596219/ https://www.ncbi.nlm.nih.gov/pubmed/36242590 http://dx.doi.org/10.18632/aging.204326

Ejemplares similares

The splicing activator DAZAP1 integrates splicing control into MEK/Erk regulated cell proliferation and migration
por: Choudhury, Rajarshi, et al.
Publicado: (2014)

The Effects of Promoter Methylation on Downregulation of DAZAP2 in Multiple Myeloma Cell Lines
por: Luo, Sai-Qun, et al.
Publicado: (2012)

DAZAP1 regulates the splicing of Crem, Crisp2 and Pot1a transcripts
por: Chen, Hsiang-Ying, et al.
Publicado: (2013)

The Structure, Expression, and Function Prediction of DAZAP2, A Down-Regulated Gene in Multiple Myeloma
por: Shi, Yiwu, et al.
Publicado: (2004)

Differential Translation of Dazap1 Transcripts during Spermatogenesis
por: Yang, Chi-Kai, et al.
Publicado: (2013)

Interaction of hnRNPA1/A2 and DAZAP1 with an Alu-Derived Intronic Splicing Enhancer Regulates ATM Aberrant Splicing
por: Pastor, Tibor, et al.
Publicado: (2011)

Alternative splicing and cancer: a systematic review
por: Zhang, Yuanjiao, et al.
Publicado: (2021)

Dazap2 modulates transcription driven by the Wnt effector TCF-4
por: Lukas, Jan, et al.
Publicado: (2009)

DAZAP2 acts as specifier of the p53 response to DNA damage
por: Liebl, Magdalena C, et al.
Publicado: (2021)

Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma
por: Chen, Yunsong, et al.
Publicado: (2020)

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability
por: Tang, Xiaozhu, et al.
Publicado: (2021)

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2021)

Pigment Intensity in Dogs is Associated with a Copy Number Variant Upstream of KITLG
por: Weich, Kalie, et al.
Publicado: (2020)

KITLG Promotes Glomerular Endothelial Cell Injury in Diabetic Nephropathy by an Autocrine Effect
por: Huang, Jiun-Chi, et al.
Publicado: (2022)

Identification of a novel mutation in the KITLG gene in a Chinese family with familial progressive hyper- and hypopigmentation
por: Wang, Jianbo, et al.
Publicado: (2021)

Childhood Adversity Is Associated With Increased KITLG Methylation in Healthy Individuals but Not in Bipolar Disorder Patients
por: He, Yujie, et al.
Publicado: (2019)

Biallelic KITLG variants lead to a distinct spectrum of hypomelanosis and sensorineural hearing loss
por: Vona, B., et al.
Publicado: (2022)

The potential role of the KFG and KITLG proteins in preventing granulosa cell apoptosis in Bubalus bubalis
por: Panwar, Deepak, et al.
Publicado: (2023)

Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo
por: Yang, Shu, et al.
Publicado: (2015)

Characterization of the mouse Dazap1 gene encoding an RNA-binding protein that interacts with infertility factors DAZ and DAZL
por: Dai, Tiane, et al.
Publicado: (2001)

NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma
por: Wei, Rongfang, et al.
Publicado: (2022)

Association of polymorphisms at the microRNA binding site of the caprine KITLG 3′-UTR with litter size
por: An, Xiaopeng, et al.
Publicado: (2016)

Cross Talk between KGF and KITLG Proteins Implicated with Ovarian Folliculogenesis in Buffalo Bubalus bubalis
por: Panwar, Deepak, et al.
Publicado: (2015)

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2022)

KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells
por: Yang, Shu, et al.
Publicado: (2014)

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2023)

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors
por: Aktas Samur, Anil, et al.
Publicado: (2022)

High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma
por: Yang, Zhaoyu, et al.
Publicado: (2020)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
por: Das, Tanuza, et al.
Publicado: (2022)

The hsa-miR-302 cluster controls ectodermal differentiation of human pluripotent stem cell via repression of DAZAP2
por: Sugawara, Tohru, et al.
Publicado: (2020)

A Copy Number Variant at the KITLG Locus Likely Confers Risk for Canine Squamous Cell Carcinoma of the Digit
por: Karyadi, Danielle M., et al.
Publicado: (2013)

A Functional p53 Responsive Polymorphism in KITLG, rs4590952, Does not Affect the Risk of Breast Cancer
por: Chen, Wei, et al.
Publicado: (2014)

De novo mutation in KITLG gene causes a variant of Familial Progressive Hyper‐ and Hypo‐pigmentation (FPHH)
por: Gorenjak, Mario, et al.
Publicado: (2021)

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2022)

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2023)

Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway
por: Liu, Enze, et al.
Publicado: (2023)

MiR-320a upregulation improves IL-1β-induced osteoarthritis via targeting the DAZAP1 and MAPK pathways
por: Mao, Jing, et al.
Publicado: (2023)

Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication
por: Zhang, Yuanjiao, et al.
Publicado: (2022)

Differentiation of fetal hematopoietic stem cells requires ARID4B to restrict autocrine KITLG/KIT-Src signaling
por: Young, In-Chi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lsdgrfdj4e4e6hbk7su8n2si16